Press release
Somavert Market Is Likely to Experience a Tremendous Growth by 2029
Somavert Market is estimated to grow at a significant CAGR during the forecast period. Somavert is a human-made protein, similar to the growth hormone of humans. Pegvisomant binds to the body receptor and blocks the effects of the growth hormone. Somavert is typically given without successful symptom treatment after other medications, surgery or radiation have been treated. Somavert is an enzyme or drug that is used to treat the hormone acromegaly that causes excessive growth hormone (EGH) in adults. In body areas such as the hands, feet and face, patients with this disease have large bones. Acromegaly is the result of non-cancerous growth and affects mostly mid-aged adults. The enzyme can inhibit GH expansion as a growth hormone receptor antagonist and return blood insulin growth factor I (IGF-I) levels in patients with acromegaly to normal.Global awareness of hormone problem drugs and therapies is increasing is the driving factor that is driving the market expansion. The improved overall clinical status of the patient as a result of treatment has contributed significantly to the growth of the market. The rise in the number of patients, particularly among adults, with this rare disease increases the demand for this drug that is expected to significantly boost the market growth. Technological advances and increased R&D expenses in the discovery of innovative products by major manufacturers offer advanced opportunities that boost the market growth.
Somavert (pegvisomant) is a sterile, white lyophilized injector for reconstitution in subcutaneous form. The Somavert packages are supplied with a separate glass vial that includes sterile injection water, USP, a sterile non-pyrogenic water preparation for injection that does not contain a diluent bacteriostatic, antimicrobial agent, and buffer. Somavert (Pegvisomant for injecting) has been approved by the FDA to treat acromegaly in patients who have had or are not appropriate for inadequate response with surgery and radiation therapy and other medical treatments.
To Request a Sample of our Report on Somavert Market: https://www.omrglobal.com/request-sample/somavert-market
Market Coverage
The market number available for - 2022-2030
Base year- 2022
Forecast period- 2023-2030
Segments Covered
By Type
By Application
Regions Covered
North America
Europe
Asia-Pacific
Rest of the world
Competitive Landscape- Chiasma, Inc., F.Hoffmann La Roche, Ltd., Boehringer Ingelheim International GmbH, Novartis AG, and Ipsen Group., among others.
A full Report of Somavert Market is Available at: https://www.omrglobal.com/industry-reports/somavert-market
Somavert Drug Market by Segments
By Type
Prefilled
Non-Prefilled
By application
Hospital
Pharmacy
Somavert Drug Market by Regions
North America
United States
Canada
Europe
UK
Germany
Spain
France
Italy
Rest of Europe
Asia-Pacific
India
China
Japan
South Korea
Rest of APAC
Rest of The World
Latin America
Middle East & Africa
Reasons to buy from us -
We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/somavert-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Somavert Market Is Likely to Experience a Tremendous Growth by 2029 here
News-ID: 3309030 • Views: …
More Releases from Orion Market Research

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…

Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…

Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…

Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for Somavert
Global Somavert Market Analysis 2025-2030: Growth Drivers, Challenges, And Oppor …
The Somavert Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]._x000D_
_x000D_
How Big Is the Somavert Market Size Expected to Be by 2034?_x000D_
The size of the somavert market has been expanding consistently over the past few years. It is anticipated to rise from $257.94 million in…
Somavert Market Comprehensive Research Study, Business Overview and Regional For …
The Somavert market size for the year 2024 is estimated to be around USD 275 million. It is anticipated to reach approximately USD 350 million by 2033, growing at a compound annual growth rate (CAGR) of about 3.2% from 2025 to 2033.
Request a sample copy of this report at: https://www.omrglobal.com/request-sample/somavert-market
Somavert Market Overview:
The Somavert market is centered around the treatment of acromegaly, a rare hormonal disorder caused by excess growth hormone.…
Somavert Market Overview: Growth, Share, Value, Size, and Scope
In 2023, the global Somavert (pegvisomant) market was valued at approximately USD 252.8 million. It is projected to reach around USD 315.6 million by 2030, with a compound annual growth rate (CAGR) of 3.3% during the forecast period from 2024 to 2030.
Somavert Market Overview
The Somavert Market is driven by the increasing prevalence of acromegaly, a rare hormonal disorder caused by excess growth hormone production. Somavert (pegvisomant), developed by…
Key Somavert Market Driver for 2025-2034: Rising Acromegaly Prevalence Drives So …
"What Is the Future Outlook for the Somavert Market's Size and Growth Rate?
Steady expansion has been observed in the somavert market size in the past few years. The market is projected to escalate from $257.94 million in 2024 to $270.68 million in 2025, demonstrating a compound annual growth rate (CAGR) of 4.9%. The growth witnessed in the historical period can be linked to increased recognition of uncommon endocrine disorders, approval…
Somavert Market to see Huge Growth by 2029
Somavert Market is estimated to grow at a significant CAGR during the forecast period. Somavert is a human-made protein, similar to the growth hormone of humans. Pegvisomant binds to the body receptor and blocks the effects of the growth hormone. Somavert is typically given without successful symptom treatment after other medications, surgery or radiation have been treated. Somavert is an enzyme or drug that is used to treat the hormone acromegaly…
Somavert Market 2019: Worldwide Industry Production, Sales, Share, Future Trends …
The global Somavert Market 2019 research is a professional and in-depth study on the current state of the industry and provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.
This report presents the worldwide Somavert Market size (value, production and consumption), splits the breakdown (data status 2014-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market…